Bradykinin B1 antagonists
US8623859B2 · kind B2 · utility
7Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 10, 2009 |
| Grant date | Jan 7, 2014 |
| Priority date | — |
| Expiry date | Aug 10, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compounds of formula (I) wherein R1, R1a, R1b, R2, R3 and X, X1, X2, X3 have the meaning as cited in the description and the claims. Said compounds are useful as Bradykinin B1 antagonists. The invention also relates to pharmaceutical compositions, the preparation of such compounds as well as the production and use as medicament.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.